Post by SnakeGirl on Nov 19, 2008 23:30:29 GMT -5
From Reptiles Magazine, March 2007 issue
Abbot Laboratories
Acquired Knoll Pharmaceuticals from 3M, which is developing ANCROD — a substance formulated from the venom of the Malayan pit viper (Callaselasma rhodostoma) to be administered following a stroke. Epibatide, from poison frogs, was recently dropped by Abbot for an application for the treatment of pain.
Amylin Pharmaceuticals
Developed a peptide from the saliva of the Gila monster (Heloderma suspectum) that promotes the release of insulin. It has been licensed to Eli Lilly for $750 million.
Cognetix
Developing the anticholinergic peptides from cone snail (Conus spp.) venom for stroke therapy.
COR Therapeutics and Schering-Plough Corp
Co-market Integrilin, known generically as eptifibatide, which is based on a protein called disintegrin taken from the venom of pigmy rattlesnakes (Sistrurus miliarius).
Elan Pharmaceuticals
Purchased Neurex to acquire rights to SNX111 (Ziconitide), a pain-killing peptide from Conus snails.
Merck
Produces a heart drug called Aggrastat, which is also based on disintegrin — this non-peptide agent is taken from the African saw-scaled viper (Echis carinatus).
Nutra Pharma Corporation and ReceptoPharm
Researching Indian cobra (Naja naja) venom for the treatment of HIV and MS.
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Quote from the article Snakes in Medicine: From the Greeks to the FDA, By Rik J. Deitsch
"Today, snake venom is being studied to develop treatments for pain, cancer, multiple sclerosis (MS), acquired immunodeficiency syndrome (AIDS), adrenomyeloneuropathy (AMN), and amyotrophic lateral sclerosis (ALS).
"One company conducting such research is Celtic Biotech. Located in Dublin, Ireland, this small biotechnology company is currently researching therapeutic properties of South American rattlesnake (Crotalus durissus) venom as a treatment for cancer. Their research shows that the principal neurotoxin from this venom may be used for treating pain and could possibly provide a substitute for morphine."
Abbot Laboratories
Acquired Knoll Pharmaceuticals from 3M, which is developing ANCROD — a substance formulated from the venom of the Malayan pit viper (Callaselasma rhodostoma) to be administered following a stroke. Epibatide, from poison frogs, was recently dropped by Abbot for an application for the treatment of pain.
Amylin Pharmaceuticals
Developed a peptide from the saliva of the Gila monster (Heloderma suspectum) that promotes the release of insulin. It has been licensed to Eli Lilly for $750 million.
Cognetix
Developing the anticholinergic peptides from cone snail (Conus spp.) venom for stroke therapy.
COR Therapeutics and Schering-Plough Corp
Co-market Integrilin, known generically as eptifibatide, which is based on a protein called disintegrin taken from the venom of pigmy rattlesnakes (Sistrurus miliarius).
Elan Pharmaceuticals
Purchased Neurex to acquire rights to SNX111 (Ziconitide), a pain-killing peptide from Conus snails.
Merck
Produces a heart drug called Aggrastat, which is also based on disintegrin — this non-peptide agent is taken from the African saw-scaled viper (Echis carinatus).
Nutra Pharma Corporation and ReceptoPharm
Researching Indian cobra (Naja naja) venom for the treatment of HIV and MS.
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
Quote from the article Snakes in Medicine: From the Greeks to the FDA, By Rik J. Deitsch
"Today, snake venom is being studied to develop treatments for pain, cancer, multiple sclerosis (MS), acquired immunodeficiency syndrome (AIDS), adrenomyeloneuropathy (AMN), and amyotrophic lateral sclerosis (ALS).
"One company conducting such research is Celtic Biotech. Located in Dublin, Ireland, this small biotechnology company is currently researching therapeutic properties of South American rattlesnake (Crotalus durissus) venom as a treatment for cancer. Their research shows that the principal neurotoxin from this venom may be used for treating pain and could possibly provide a substitute for morphine."